Observational studyBMC musculoskeletal disorders2026
Association of serum vitamin D levels with clinical severity and recovery duration in cervical dizziness.
Observational study in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical dizziness (CD) is associated with altered cervical musculoskeletal and proprioceptive input, leading to impaired sensorimotor integration and balance control. Vitamin D deficiency has been linked to musculoskeletal pain, muscle dysfunction, and impaired postural stability; however, its role in CD remains unclear.
methodsThis prospective observational study included 210 patients diagnosed with CD. Serum 25-hydroxyvitamin D [25(OH)D] levels were measured at baseline, and participants were categorized into deficiency (< 20 ng/mL), insufficiency (20-29 ng/mL), and sufficiency (≥ 30 ng/mL) groups. All patients received a standardized multimodal cervical rehabilitation program, with vitamin D supplementation provided to the deficient and insufficient groups. Clinical outcomes were assessed using the Neck Disability Index (NDI), Dizziness Handicap Inventory (DHI), and Vertigo Dizziness Imbalance questionnaires (VDI-SS and VDI-QOL). Associations between vitamin D levels, baseline symptom severity, and recovery duration were analyzed using correlation, multivariable regression, receiver operating characteristic (ROC) analysis, and partial least squares discriminant analysis (PLS-DA).
resultsLower serum 25(OH)D levels were significantly associated with higher baseline NDI, DHI, VDI-SS, and VDI-QOL scores (all p < 0.001), indicating greater symptom severity and functional impairment. Serum 25(OH)D levels showed a strong inverse correlation with recovery duration (rho = -0.77, p < 0.001) and remained associated with a longer recovery duration in multivariable linear regression. ROC analysis demonstrated high discriminatory performance for delayed recovery (AUC = 0.937), with an exploratory optimal threshold of ≤ 17 ng/mL. In exploratory PLS-DA, serum 25(OH)D contributed more to group separation than did age, sex, or BMI.
conclusionsLower serum vitamin D levels were associated with greater baseline clinical severity and longer recovery duration in patients with CD. These findings suggest that vitamin D status may be clinically relevant in the assessment of disease severity and recovery in this population. Further prospective controlled studies are required to clarify the clinical significance of this association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.